Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

A study last year indicated that patients taking semaglutide were at significantly reduced risk of being diagnosed with Alzheimer’s. Novo Nordisk is testing whether the ingredient — which is ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Nobody designed GLP-1s to reduce Alzheimer’s disease.” Nigel Greig ... The Food and Drug Administration has approved ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

They decreased the risk of psychotic disorders by 18%, Alzheimer’s disease by 12% and addiction disorders by an average of 13%. Novo Nordisk markets its blockbuster semaglutide (GLP-1 ...

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase eightfold in a decade as therapies address unmet medical need.

Those benefits included reduced risks of neurocognitive disorders like Alzheimer’s and dementia ... following statement to Fox News Digital. "Semaglutide has helped millions of people fight ...